R&D Systems™ Human NELL2, Carrier-Free Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems™ 8946NL050
DescriptionThe Recombinant Human NELL2 Protein is derived from NS0. The Recombinant Human NELL2 Protein has been validated for the following applications: Bioactivity.
|Mouse myeloma cell line, NS0-derived Leu22-Leu816, with a C-terminal 6-His tag|
|Observed M.W.: 100-125kDa, reducing conditions, Theoretical M.W.: 90kDa|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|
|Mel91, nel (chicken)-like 2, NEL-like 2 (chicken), NEL-like protein 2, Nel-related protein 2, NRP2, NRP2neural epidermal growth factor-like 2, protein kinase C-binding protein NELL2|
|>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining|
|Mouse myeloma cell line,NS0-derived human NELL2 protein Leu22-Leu816,with a C-terminal 6-His tag|
|<0.10 EU per 1μg of the protein by the LAL method.|
|Measured by the ability of the immobilized protein to support the adhesion of C3H10T1/2 mouse embryonic fibroblast cells. The ED50 for this effect is typically 0.3-1.8μg/mL.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok